The World Health Organization director for Africa said Uganda has started a clinical trial of a vaccine against the Sudan strain of Ebola, for which there is currently no approved vaccine.

A Sudan Ebola vaccine, provided by the International AIDS Vaccine Initiative (IAVI), is being investigated in a Uganda ...

An effort to test several Ebola Sudan vaccines in Uganda in 2022 was abandoned because the outbreak was contained before the trial could be done. This time, years of planning to persuade countries ...

In 2022, during a previous outbreak of Ebola from the Sudan strain in Uganda, a randomized protocol for candidate vaccines ...

First Participants Vaccinated with IAVI’s Ebola Sudan Vaccine Candidate in Uganda Amid Ebola Outbreak ACCESSWIRE. Updated February 3, 2025 11:25 AM.

More about IAVI's investigational Ebola Sudan vaccine candidate. In 2023, IAVI initiated a Phase 1 clinical trial of its rVSV-based Ebola Sudan vaccine candidate.

Of the five other Ebola species, just one has licensed vaccines. The deadliest Ebola epidemic killed more than 11,300 people in West Africa between 2013 and 2016.

While there is no approved vaccine for the Sudan Ebola strain, a vaccine for the Zaire Ebola strain – which caused the 2013-2016 West Africa epidemic that killed more than 11,000 people – was ...

KAMPALA, Uganda — Ugandan authorities on Monday began a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in the outbreak declared last week.

More about IAVI's investigational Ebola Sudan vaccine candidate. In 2023, IAVI initiated a Phase 1 clinical trial of its rVSV-based Ebola Sudan vaccine candidate.

More about IAVI's investigational Ebola Sudan vaccine candidate. In 2023, IAVI initiated a Phase 1 clinical trial of its rVSV-based Ebola Sudan vaccine candidate.

More about IAVI's investigational Ebola Sudan vaccine candidate. In 2023, IAVI initiated a Phase 1 clinical trial of its rVSV-based Ebola Sudan vaccine candidate.